✦ LIBER ✦

Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer

✍ Scribed by Stiles, B M; Adusumilli, P S; Bhargava, A; Stanziale, S F; Kim, T H; Chan, M-K; Huq, R; Wong, R; Rusch, V W; Fong, Y

Book ID: 110019262
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 428 KB
Volume: 13
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700860

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot Study of Oncolytic Viral Therapy U

Pilot Study of Oncolytic Viral Therapy Using Mutant Herpes Simplex Virus (HF10) Against Recurrent Metastatic Breast Cancer

✍ Hideto Kimata; Tsuneo Imai; Toyone Kikumori; Osamu Teshigahara; Tetsuro Nagasaka 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 205 KB

Oncolytic herpes simplex viral therapy e

Oncolytic herpes simplex viral therapy effectively treats and improves survival in a murine model of pleural malignant mesothelioma

✍ Prasad S. Adusumilli; Brendon M. Stiles; Mei-Ki Chan; Valerie W. Rusch; Yuman Fo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Impact of new oncolytic herpes simplex v

Impact of new oncolytic herpes simplex virus for cervical cancer therapy

✍ Kagabu, M.; Miura, Y.; Takeshita, R.; Yoshino, N.; Sugiyama, T. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Gene Therapy of Cancer || Selectively Re

Gene Therapy of Cancer || Selectively Replicating Herpes Simplex Viral Vectors

✍ White, Edward 📂 Article 📅 2014 🏛 Elsevier ⚖ 360 KB

Oncolytic herpes simplex viral therapy i

Oncolytic herpes simplex viral therapy is effective in the treatment of hepatocellular carcinoma cell lines

✍ SONG, T; EISENBERG, D; ADUSUMILLI, P; HEZEL, M; FONG, Y 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 53 KB

Development of a second-generation oncol

Development of a second-generation oncolytic Herpes simplex virus expressing TNFα for cancer therapy

✍ Z. Q. Han; M. Assenberg; B. L. Liu; Y. B. Wang; G. Simpson; S. Thomas; R. S. Cof 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

## Abstract ## Background Tumour necrosis factor alpha (TNFα) therapy is a promising anti‐cancer treatment when combined with radiotherapy due to its potent radio sensitising effects, but systemic toxicity has limited its clinical use. Previously, non‐replicative adenovirus vectors have been used